Breaking News Instant updates and real-time market news.

AMZN

Amazon.com

$1,495.60

-16.07 (-1.06%)

07:20
11/21/18
11/21
07:20
11/21/18
07:20

Amazon opens Spanish pop-up store, Reuters reports

Amazon opened its first pop-up store in Spain selling everything from electronic goods to video games to clothing and will open similar stores in Italy, Germany and Britain, Reuters reports, citing an Amazon spokeswoman. The European pop-up locations signal how the online retailer is increasingly turning to physical stores to attract and retain customers. Reference Link

  • 28

    Nov

  • 04

    Dec

AMZN Amazon.com
$1,495.60

-16.07 (-1.06%)

11/19/18
RBCM
11/19/18
INITIATION
Target $12
RBCM
Outperform
ADT Inc. initiated with an Outperform at RBC Capital
RBC Capital analyst Seth Weber initiated ADT Inc (ADT) with an Outperform rating and a price target of $12. The analyst cites the company's position as a leading provider in the $28B North America monitored security industry serving over 8M customers. Given the 27% short interest, Weber says ADT is a battleground stock, but he also believes that the perceived risk of competition from Amazon (AMZN) is overstated and that the company's big free cash flows outweighs its high leverage.
11/19/18
JEFF
11/19/18
NO CHANGE
JEFF
Jefferies uncovers signs of Amazon expanding prescription drug presence
Jefferies analyst Brian Tanquilut says his proprietary checks of Amazon.com's (AMZN) moves in the pharmacy space indicate that the online retailer has finally made moves to expand PillPack. However, the initial expansion phase appears focused on offering pharmacy services to Amazon employees in Washington. In his most recent webscrape, Tanquilut came across a new prescription license in WA, two pending Rx licenses in New Mexico and Indiana, and pharmacy technician and packaging/shipping job postings all linked to PillPack's Phoenix facility. These new developments signal the beginning of Amazon's prescription expansion via PillPack, Tanquilut tells investors in a research note. If Amazon were to rollout a more extensive PillPack offering to its own employee base, Rite Aid (RAD) could be most exposed to potential script transfers with Walgreens Boots Alliance (WBA) the least exposed among the public drugstores, says the analyst. He still believes that the impact of Amazon's pharmacy entry will take a while to materialize for drug stores CVS Health (CVS) and Walgreens.
11/16/18
MKMP
11/16/18
NO CHANGE
Target $415
MKMP
Buy
Netflix, Amazon price targets raised at MKM Partners
MKM Partners analyst Rob Sanderson raised his price targets on Buy rated Netflix (NFLX) and Amazon (AMZN) to $415 from $395 and $2,240 from $2,215 respectively as part of his broader research note titled "Victims of Risk-off Environment; Recommend Buying Weakness". The analyst states that these stocks have been among the weaker performers in the underperforming Internet sector, but should become "excellent performers" over the next 12 months if his view attributing the recent correction in the broader market to a late-cycle pause amidst geo-political uncertainty and Fed concerns proves to be correct. As part of this research note, Sanderson also keeps his Buy rating on Spotify (SPOT) but lowers its price target to $200 from $245, applying a 25-times forward earnings multiple in rolling out his valuation to 2022, with added currency related pressure against the "much less contentious" expected renewal rates in 2019.
11/16/18
KEYB
11/16/18
INITIATION
Target $110
KEYB
Overweight
Target initiated with an Overweight at KeyBanc
KeyBanc analyst Edward Yruma initiated Target (TGT) with an Overweight rating and $110 price target. The analyst says Target's investments and improved execution are driving stronger comps, telling investors in a research note that he thinks this is sustainable in the current environment. Rather than viewing Target as a participant in the Amazon (AMZN) vs. Walmart (WMT) battle, Yruma thinks its unique mix of consumables and high-margin apparel/home decor leave it well-positioned to take share from at-risk retailers.

TODAY'S FREE FLY STORIES

LXFR

Luxfer

$19.06

-2.36 (-11.02%)

12:00
12/18/18
12/18
12:00
12/18/18
12:00
Hot Stocks
Luxfer falls -10.9% »

Luxfer is down -10.9%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

BPT

BP Prudhoe Bay

$22.75

-2.745 (-10.77%)

12:00
12/18/18
12/18
12:00
12/18/18
12:00
Hot Stocks
BP Prudhoe Bay falls -11.2% »

BP Prudhoe Bay is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$81.94

-11.81 (-12.60%)

12:00
12/18/18
12/18
12:00
12/18/18
12:00
Hot Stocks
VelocityShares 3x Inv Natural Gas ETN falls -12.4% »

VelocityShares 3x Inv…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DWT

Britannia Bulk

$16.08

1.7 (11.82%)

12:00
12/18/18
12/18
12:00
12/18/18
12:00
Hot Stocks
Britannia Bulk rises 11.7% »

Britannia Bulk is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UGAZ

VelocityShares 3x Long Natural Gas ETN

$81.37

8.68 (11.94%)

12:00
12/18/18
12/18
12:00
12/18/18
12:00
Hot Stocks
VelocityShares 3x Long Natural Gas ETN rises 11.9% »

VelocityShares 3x Long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NAV

Navistar

$26.90

3.06 (12.84%)

12:00
12/18/18
12/18
12:00
12/18/18
12:00
Hot Stocks
Navistar rises 12.8% »

Navistar is up 12.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

VLKAY

Volkswagen

$0.00

(0.00%)

11:57
12/18/18
12/18
11:57
12/18/18
11:57
Periodicals
Volkswagen seen gaining edge in German test case, Bloomberg says »

Volkswagen will more…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWLO

Twilio

$84.00

-3.45 (-3.95%)

11:55
12/18/18
12/18
11:55
12/18/18
11:55
Options
Twilio put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 20

    Dec

11:55
12/18/18
12/18
11:55
12/18/18
11:55
Conference/Events
RBC Capital retail-hardlines analyst to hold a group luncheon »

Retail/Hardlines Analyst…

ADTN

Adtran

$10.92

-0.05 (-0.46%)

11:51
12/18/18
12/18
11:51
12/18/18
11:51
Earnings
Adtran announces CAF II solutions to address rural U.S. areas without broadband »

Adtran announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:50
12/18/18
12/18
11:50
12/18/18
11:50
General news
FX Action: USD-CAD »

FX Action: USD-CAD has…

FB

Facebook

$143.24

2.93 (2.09%)

11:47
12/18/18
12/18
11:47
12/18/18
11:47
Hot Stocks
Facebook COO Sandberg says needs to step up efforts to curb misinformation »

Facebook COO Sheryl…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMT

American Tower

$162.39

1.47 (0.91%)

11:45
12/18/18
12/18
11:45
12/18/18
11:45
Conference/Events
American Tower management to meet with SunTrust »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

CPRX

Catalyst Pharmaceuticals

$2.43

0.085 (3.62%)

, ENDP

Endo

$9.45

(0.00%)

11:43
12/18/18
12/18
11:43
12/18/18
11:43
Hot Stocks
Catalyst Pharmaceuticals, Endo sign definitive agreement for vigabatrin tablets »

Catalyst Pharmaceuticals…

CPRX

Catalyst Pharmaceuticals

$2.43

0.085 (3.62%)

ENDP

Endo

$9.45

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$17.39

-0.26 (-1.47%)

11:40
12/18/18
12/18
11:40
12/18/18
11:40
Options
Put buyer in Teva Pharmaceuticals appears to adjust week-old position »

Put buyer in Teva…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:40
12/18/18
12/18
11:40
12/18/18
11:40
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

AMTB

Mercantil Bank

$12.30

(0.00%)

11:39
12/18/18
12/18
11:39
12/18/18
11:39
Hot Stocks
Breaking Hot Stocks news story on Mercantil Bank »

Mercantil Bank Holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Dec

AXGN

AxoGen

$26.39

-1.14 (-4.14%)

11:38
12/18/18
12/18
11:38
12/18/18
11:38
Periodicals
AxoGen mentioned cautiously in a Seeking Alpha article 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMTB

Mercantil Bank

$12.30

(0.00%)

11:34
12/18/18
12/18
11:34
12/18/18
11:34
Hot Stocks
Breaking Hot Stocks news story on Mercantil Bank »

Mercantil Bank Holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Dec

MXIM

Maxim Integrated

$52.71

0.51 (0.98%)

, INTC

Intel

$48.02

0.93 (1.97%)

11:30
12/18/18
12/18
11:30
12/18/18
11:30
Recommendations
Maxim Integrated, Intel, Inphi, Cisco, Macom analyst commentary  »

Cisco acquisition of…

MXIM

Maxim Integrated

$52.71

0.51 (0.98%)

INTC

Intel

$48.02

0.93 (1.97%)

IPHI

Inphi

$33.50

0.96 (2.95%)

CSCO

Cisco

$44.04

-0.17 (-0.38%)

MTSI

Macom

$15.86

0.46 (2.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jan

  • 07

    Jan

  • 08

    Jan

  • 10

    Jan

  • 04

    Mar

CBIO

Catalyst Biosciences

$8.93

-0.33 (-3.56%)

11:25
12/18/18
12/18
11:25
12/18/18
11:25
Conference/Events
Catalyst Biosciences to host research and development day »

Research and Development…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

WCG

WellCare

$231.35

-5.81 (-2.45%)

11:25
12/18/18
12/18
11:25
12/18/18
11:25
Conference/Events
WellCare management to meet with Wolfe Research »

Healthcare Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

PM

Philip Morris

$78.59

-2.8 (-3.44%)

, BTI

British American Tobacco

$32.48

-0.25 (-0.76%)

11:23
12/18/18
12/18
11:23
12/18/18
11:23
On The Fly
Fly Intel: Today's top analyst calls on Wall Street »

Check out today's top…

PM

Philip Morris

$78.59

-2.8 (-3.44%)

BTI

British American Tobacco

$32.48

-0.25 (-0.76%)

IMBBY

Imperial Brands

$0.00

(0.00%)

TSLA

Tesla

$346.73

-1.57 (-0.45%)

ORCL

Oracle

$45.66

-0.06 (-0.13%)

OSTK

Overstock.com

$13.06

-0.45 (-3.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jan

  • 16

    Jan

  • 17

    Jan

USO

United States Oil Fund

$10.10

-0.345 (-3.30%)

11:20
12/18/18
12/18
11:20
12/18/18
11:20
Options
New 52wk lows prompt bullish risk reversal in US Oil ETF »

New 52wk lows prompt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPS

Cooper-Standard

$64.54

1.26 (1.99%)

11:18
12/18/18
12/18
11:18
12/18/18
11:18
Hot Stocks
Cooper-Standard announces plans for new world headquarters »

Cooper Standard announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.